Clinical trial Recruiting at 1 site Interventional Ages 65 to 99

A new propofol dosing method for people over 65 based on frontal EEG

Official title: Development of a Pharmacodynamic Model for Propofol in Older Adults (Development phaRmacodynamic mOdel Propofol oLdEr adulTs: DROPLET)

Run by Pontificia Universidad Catolica de Chile · NCT05790720 · Data updated 2026-11-12

We will test a new propofol dosing method that uses frontal EEG signals to guide anesthesia for people over 65 having non-cardiac elective surgery.

Quick facts

Study typeInterventional
Ages65 Years to 99 Years
SexAll
Enrollment36 (estimated)
SponsorPontificia Universidad Catolica de Chile
Academic / other
Locations1 site (Santiago, Santiago Metropolitan)
StatusRecruiting
StartedJune 1, 2024
Main results expectedJuly 1, 2026
Study endsAugust 1, 2026
Registry record updatedJune 26, 2026
Trial IDNCT05790720 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults older than 65 scheduled for non-cardiac elective surgery under general anesthesia with ASA physical status I–III.

Probably not a fit

Patients undergoing emergency or neurosurgical procedures, those with BMI ≥35, unstable heart failure, active substance abuse, or a known propofol allergy are excluded and unlikely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional pharmacodynamic project enrolls older adults who will receive propofol infusions while continuous frontal EEG and BIS are recorded. Investigators will use the Eleveld pharmacokinetic model to estimate plasma concentrations and derive a new pharmacodynamic parameter from intraoperative frontal EEG to represent drug effect. The study will compare the predictive performance of the standard Eleveld PKPD model based on BIS with the new EEG-derived model, correlating both with clinical signs of loss and return of consciousness. Participants will complete preoperative questionnaires and be monitored for safety during anesthesia at Pontificia Universidad Católica de Chile.

Why it matters

Potential benefit: If successful, the approach could let clinicians dose propofol more precisely in older adults, reducing overdose or underdose and improving safety and recovery.

How similar studies have gone: Existing PKPD models such as Eleveld's have performed across age ranges but relied on BIS and included few patients over 70, so using an EEG-derived PD parameter in older adults is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients undergoing non-cardiac elective surgery requiring general anesthesia
* American Society of Anesthesiologists Physical Status I to III

Exclusion Criteria:

* Patients undergoing emergency surgery
* Neurosurgical patients
* History of alcohol abuse or recreational drug use
* Known allergie to Propofol
* Body mass index ≥ 35 Kg m-2
* Unstable heart failure

Where it's running

  • Pontificia Universidad Católica de Chile
    Santiago, Santiago Metropolitan, Chile
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.